Shi-Jun Xu

Dr. Shi-Jun Xu

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2019 in Cells
Verified
Journal Article
Open access
PDF file
SXShi-Jun Xu
Shi-Jun Xu
HHHong Tao Hu
Hong Tao Hu
HLHai-Liang Li
Hai-Liang Li
Suhwan ChangSuhwan Chang
Suhwan Chang
The tumor microenvironment (TME) is the primary arena where tumor cells and the host immune system interact. Bidirectional communication between tumor cells and the associated stromal cell types within the TME influences disease initiation and progression, as well as tumor immunity. Macrophages and natural killer (NK) cells are crucial components of the stromal compartment and display either pro- or anti-tumor properties, depending on the expression of key regulators. MicroRNAs (miRNAs) are emerging as such regulators. They affect several immune cell functions closely related to tumor evasion of the immune system. This review discusses the role of miRNAs in the differentiation, maturation, and activation of immune cells as well as tumor immunity, focusing particularly on macrophages and NK cells.

8 February 2019 in eLife
Verified
Journal Article
Open access
HXHui Xu
Hui Xu
SXShi-Jun Xu
Shi-Jun Xu
SXShu-Juan Xie
Shu-Juan Xie
YZYin Zhang
Yin Zhang
JYJian-Hua Yang
Jian-Hua Yang
LQLiang-Hu Qu
Liang-Hu Qu
MicroRNA-122 (miR-122) is the most abundant microRNA in hepatocytes and a central player in liver biology and disease. Herein, we report a previously unknown role for miR-122 in hepatocyte intrinsic innate immunity. Restoration of miR-122 levels in hepatoma cells markedly enhanced the activation of interferons (IFNs) in response to a variety of viral nucleic acids or simulations, especially in response to hepatitis C virus RNA and poly (I:C). Mechanistically, miR-122 downregulated the phosphorylation (Tyr705) of STAT3, thereby removing the negative regulation of STAT3 on IFN-signaling. STAT3 represses IFN expression by inhibiting interferon regulatory factor 1 (IRF1), whereas miR-122 targets MERTK, FGFR1 and IGF1R, three receptor tyrosine kinases (RTKs) that directly promote STAT3 phosphorylation. This work identifies a miR-122–RTKs/STAT3–IRF1–IFNs regulatory circuitry, which may play a pivotal role in regulating hepatocyte innate immunity. These findings renewed our knowledge of miR-122’s function and have important implications for the treatment of hepatitis viruses.

16 April 2018 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
HXHui Xu
Hui Xu
JHJie‐Hua He
Jie‐Hua He
SXShi-Jun Xu
Shi-Jun Xu
SXShu‐Juan Xie
Shu‐Juan Xie
LMLi‐Ming Ma
Li‐Ming Ma
LQLiang-Hu Qu
Liang-Hu Qu

29 August 2026 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
JWJiutao Wang
Jiutao Wang
SXShi-Jun Xu
Shi-Jun Xu
XTXueli Tian
Xueli Tian
HCHui Chang
Hui Chang
XZXin Zhao
Xin Zhao
DYDongchuan Yu
Dongchuan Yu
Cellular transdifferentiation enables tumor cells to alter differentiated phenotypes, acquiring capabilities, such as invasiveness, stemness, or drug resis

19 January 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
HXHui Xu
Hui Xu
SXShi-Jun Xu
Shi-Jun Xu
SXShu-Juan Xie
Shu-Juan Xie
YZYin Zhang
Yin Zhang
JYJian-Hua Yang
Jian-Hua Yang
LQLiang-Hu Qu
Liang-Hu Qu
The intrinsic innate immunity of hepatocytes is essential for the control of hepatitis viruses and influences the outcome of antiviral therapy. MicroRNA-122 (miR-122) is the most abundant microRNA in hepatocytes and is a central player in liver biology and disease. However, little is known about the role of miR-122 in hepatocyte innate immunity. Herein, we show that restoring miR-122 levels in hepatoma cells markedly increased the activation of both type III and type I interferons (IFNs) in response to hepatitis C virus (HCV) RNA or poly(I:C). We determined that miR-122 promotes IFN production through down-regulating the tyrosine (Tyr705) phosphorylation of STAT3. We show that STAT3 represses IFN activation by inhibiting interferon regulatory factor 1 (IRF1), which is rate-limiting for maximal IFN expression, especially type III IFNs. Through large-scale screening, we identified that miR-122 targets MERTK, FGFR1 and IGF1R, three oncogenic receptor tyrosine kinases that directly promote STAT3 phosphorylation. These findings reveal a previously unknown role for miR-122 in hepatic immunity and indicate a new potential strategy for treating hepatic infections through targeting STAT3.